cyclosporine has been researched along with Dysgeusia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biglia, A; Bozzalla Cassione, E; Cavagna, L; Codullo, V; Montecucco, C; Zanframundo, G | 1 |
| Alanis, LR; Casagrande, RW; Dantas, SA; de Lima, AA; Dirschnabel, AJ; Grégio, AM; Ignacio, SA; Machado, MÂ; Martins, Ade S; Ribas, Mde O; Trevilatto, PC | 1 |
2 other study(ies) available for cyclosporine and Dysgeusia
| Article | Year |
|---|---|
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Cyclosporine; Diarrhea; Dysgeusia; Dyspnea; Fatigue; Female; Fever; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Incidence; Intensive Care Units; Italy; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Respiratory Distress Syndrome; SARS-CoV-2; Telemedicine | 2020 |
Clinical oral findings in dialysis and kidney-transplant patients.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Chi-Square Distribution; Cyclosporine; Dysgeusia; Female; Gingival Overgrowth; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mouth Diseases; Renal Dialysis; Tongue Diseases; Xerostomia; Young Adult | 2011 |